Search
-
Unlock Strategic Advantage with Ipsos' New Insights Agent
Ipsos launches Insights Agent, its agentic AI solution to unlock faster, smarter decision-making by connecting your information and transforming it into impact.
-
Ipsos launches GLP-1 PersonaBot, designed to support companies’ understanding of the consumer obesity treatment market
Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.
-
Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
-
A Dose of Digital: Can Pharma Make DTx a Healthy Business?
Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.
-
ESG in life sciences as a hidden driver for brand success
There is a growing belief among the public that private corporations should also take responsibility for environmental, social, and governance (ESG) issues; these factors are no longer solely the responsibility of the public and governments. While certain business sectors are perceived as having a heightened obligation to diminish their environmental footprint (particularly energy companies, automobile manufacturers, airlines, and public transport providers), no industry can evade the necessity to act responsibly.
-
Market sizing and forecasting in the medical device & diagnostic markets
Understanding the market potential for a product is an integral part of any business plan. Assessing market size, identifying existing and new competitors – as well other drivers/constraints on growth – will inform and guide a business development plan and forecast.
-
The time is now: Telehealth and rise of virtual care
Virtual care has gained increased importance during coronavirus, but will this bring about a permanent shift in remote healthcare.
-
Healthcare focus: Maximising omnichannel customer engagement
Today’s rapid acceleration in the use of virtual channels means omnichannel engagement strategies are needed, and quickly. Your customers are now consuming and communicating information in innumerable new ways.